loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 78813 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 OXALIPLATIN (2)

02 Oxaliplatin (2)

filter

01 AqVida GmbH (2)

02 HOSPIRA WORLDWIDE (2)

filter

01 INJECTABLE;INTRAVENOUS (2)

02 SOLUTION FOR INFUSION (2)

filter

01 100MG/20ML (1)

02 100MG/20ML (5MG/ML) (1)

03 50MG/10ML (1)

04 50MG/10ML (5MG/ML) (1)

filter

01 Germany (2)

02 USA (2)

URL Supplier Web Content
SOLUTION FOR INFUSION
100MG/20ML
Germany
78813
Vial (Box)
Generic MA Granted (EU) & Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION FOR INFUSION
50MG/10ML
Germany
78813
Vial (Box)
Generic MA Granted (EU) & Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
INJECTABLE;INTRAVENOUS
100MG/20ML (5MG/ML)
OXALIPLATIN
USA
78813
2009-08-07
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
INJECTABLE;INTRAVENOUS
50MG/10ML (5MG/ML)
OXALIPLATIN
USA
78813
2009-08-07
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 78813

Looking for CTD TGA MCC DOSSIER APPLICATION 78813 4

19

AqVida GmbH, based in Germany, is a pharmaceutical company.

One of their notable products is Oxaliplatin, with a corresponding application number 78813 and regulatory information .

proudly manufactured in the

AqVida GmbH's SOLUTION FOR INFUSION, medication with 100MG/20ML of Oxaliplatin.

18

AqVida GmbH, based in Germany, is a pharmaceutical company.

One of their notable products is Oxaliplatin, with a corresponding application number 78813 and regulatory information .

proudly manufactured in the

AqVida GmbH's SOLUTION FOR INFUSION, medication with 50MG/10ML of Oxaliplatin.

17

Hospira, Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is OXALIPLATIN, with a corresponding application number 78813 and regulatory information .

proudly manufactured in the

approval since 2009-08-07

Hospira, Inc.'s OXALIPLATIN INJECTABLE;INTRAVENOUS, medication with 100MG/20ML (5MG/ML) of OXALIPLATIN.

16

Hospira, Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is OXALIPLATIN, with a corresponding application number 78813 and regulatory information .

proudly manufactured in the

approval since 2009-08-07

Hospira, Inc.'s OXALIPLATIN INJECTABLE;INTRAVENOUS, medication with 50MG/10ML (5MG/ML) of OXALIPLATIN.

Post Enquiry
POST ENQUIRY